A multi-center,double-blind,randomized,placebo-and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis

To the Editor:Atopic dermatitis(AD)is a chronic,recurrent,and inflammatory skin disease that can be accompanied by asthma,allergic rhinitis,conjunctivitis,and other diseases.[1]Topical corticosteroids are mostly used in patients with AD.Considering the side effects of the long-term use of corticosteroids,additional topical treatments could be useful.